These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

483 related items for PubMed ID: 11547461

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Clinical trials group: two studies are now open to patients who qualify.
    Craig K.
    HIV Clin; 2000; 12(1):5. PubMed ID: 11810862
    [No Abstract] [Full Text] [Related]

  • 3. [HIV infection: DuPont Pharma presents the results of its antiretroviral agent].
    Allerg Immunol (Paris); 1998 Apr; 30(4):123-4. PubMed ID: 9631694
    [No Abstract] [Full Text] [Related]

  • 4. AVANTI 2. Randomized, double-blind trial to evaluate the efficacy and safety of zidovudine plus lamivudine versus zidovudine plus lamivudine plus indinavir in HIV-infected antiretroviral-naive patients.
    AIDS; 2000 Mar 10; 14(4):367-74. PubMed ID: 10770538
    [Abstract] [Full Text] [Related]

  • 5. Buffalo hump: what the experts suggest.
    Piliero PJ, McComsey GA.
    AIDS Clin Care; 2004 Mar 10; 16(3):22-3. PubMed ID: 15119294
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Switching from protease inhibitors to the non-nuke efavirenz.
    TreatmentUpdate; 2001 Mar 10; 12(12):3. PubMed ID: 11570089
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Antiretrovirals for HIV nephropathy?
    Saag M, Hecht F.
    AIDS Clin Care; 1999 Jun 10; 11(6):50. PubMed ID: 11366883
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Triple nuke therapy--results after one year.
    TreatmentUpdate; 2001 Jun 10; 12(10):3-4. PubMed ID: 11570063
    [No Abstract] [Full Text] [Related]

  • 14. Sustiva added to three-drug combination.
    AIDS Patient Care STDS; 1998 Oct 10; 12(10):803. PubMed ID: 11362030
    [No Abstract] [Full Text] [Related]

  • 15. Comparison of two once-daily regimens with a regimen consisting of nelfinavir, didanosine, and stavudine in antiretroviral therapy-naïve adults: 48-week results from the Antiretroviral Regimen Evaluation Study (ARES).
    Lowe SH, Wensing AM, Hassink EA, ten Kate RW, Richter C, Schreij G, Koopmans PP, Juttmann JR, van der Tweel I, Lange JM, Borleffs JC.
    HIV Clin Trials; 2005 Oct 10; 6(5):235-45. PubMed ID: 16306030
    [Abstract] [Full Text] [Related]

  • 16. Update on antivirals.
    Proj Inf Perspect; 1997 Nov 10; (23):8-11. PubMed ID: 11365381
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Randomized, double-blind comparison of two nelfinavir doses plus nucleosides in HIV-infected patients (Agouron study 511).
    Saag MS, Tebas P, Sension M, Conant M, Myers R, Chapman SK, Anderson R, Clendeninn N, Virqacept Collaborative Study Group.
    AIDS; 2001 Oct 19; 15(15):1971-8. PubMed ID: 11600825
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Hypercholesterolemia in a health care worker receiving thyroxine after postexposure prophylaxis for human immunodeficiency virus infection.
    Nerad JL, Kessler HA.
    Clin Infect Dis; 2001 Jun 01; 32(11):1635-6. PubMed ID: 11340537
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.